AAAAAA
Results: 26-36/36
Authors:
Kroon, BBR
Bergman, W
Coebergh, JWW
Ruiter, DJ
Citation: Bbr. Kroon et al., Consensus on the management of malignant melanoma of the skin in the Netherlands, MELANOMA RE, 9(3), 1999, pp. 207-212
Authors:
Verbeek, MM
Otte-Holler, I
Ruiter, DJ
De Waal, RMW
Citation: Mm. Verbeek et al., Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease, CELL MOL B, 45(1), 1999, pp. 37-46
Authors:
Ruijter, ETG
Miller, GJ
Van de Kaa, CA
Van Bokhoven, A
Bussemakers, MJG
Debruyne, FMJ
Ruiter, DJ
Schalken, JA
Citation: Etg. Ruijter et al., Molecular analysis of multifocal prostate cancer lesions, J PATHOLOGY, 188(3), 1999, pp. 271-277
Authors:
de Leeuw, N
Melchers, WJG
Ruiter, DJ
Caforio, ALP
Balk, AHMM
de Jonge, N
Galama, JMD
Citation: N. De Leeuw et al., Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy, J CLIN PATH, 52(10), 1999, pp. 739-743
Authors:
Zendman, AJW
Cornelissen, IMHA
Weidle, UH
Ruiter, DJ
van Muijen, GNP
Citation: Ajw. Zendman et al., TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential, FEBS LETTER, 446(2-3), 1999, pp. 292-298
Authors:
Zendman, AJW
Cornelissen, IMHA
Weidle, UH
Ruiter, DJ
van Muijen, GNP
Citation: Ajw. Zendman et al., CTp11, a novel member of the family of human cancer/testis antigens, CANCER RES, 59(24), 1999, pp. 6223-6229
Authors:
de Vries, TJ
Fourkour, A
Punt, CJA
Diepstra, H
Ruiter, DJ
van Muijen, GNP
Citation: Tj. De Vries et al., Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood, BR J CANC, 81(6), 1999, pp. 1066-1070
Authors:
Hofmann, UB
Westphal, JR
Waas, ET
Zendman, AJW
Cornelissen, IMHA
Ruiter, DJ
van Muijen, GNP
Citation: Ub. Hofmann et al., Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression, BR J CANC, 81(5), 1999, pp. 774-782
Authors:
de Vries, TJ
Fourkour, A
Punt, CJA
van de Locht, LTF
Wobbes, T
van den Bosch, S
de Rooij, MJM
Mensink, EJBM
Ruiter, DJ
van Muijen, GNP
Citation: Tj. De Vries et al., Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR, BR J CANC, 80(5-6), 1999, pp. 883-891
Authors:
Ferrier, CM
de Witte, HH
Straatman, H
van Tienoven, DH
van Geloof, WL
Rietveld, FJR
Sweep, CGJ
Ruiter, DJ
van Muijen, GNP
Citation: Cm. Ferrier et al., Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue, BR J CANC, 79(9-10), 1999, pp. 1534-1541
Authors:
Kremer, H
Lavrijsen, APM
McLean, WHI
Lane, EB
Melchers, D
Ruiter, DJ
Mariman, ECM
Steijlen, PM
Citation: H. Kremer et al., An atypical form of bullous congenital ichthyosiform erythroderma is caused by a mutation in the L12 linker region of keratin 1, J INVES DER, 111(6), 1998, pp. 1224-1226